#United States #Cambridge #Red Blood Cells #Safi Biotherapeutics #DesiCorp

Safi Biotherapeutics and DesiCorp Form Strategic Collaboration

In a groundbreaking move to enhance medical care in challenging environments, Safi Biotherapeutics Inc. and DesiCorp Inc. have announced a collaboration aimed at freeze-drying manufactured human red blood cells (mRBCs). This innovative joint effort promises to provide a highly portable and shelf-stable alternative to traditional donor blood products, making a significant impact on emergency medical situations, military operations, and mass-casualty incidents.

The partnership leverages the unique expertise each company brings to the table: Safi Biotherapeutics excels in producing stem-cell-derived red blood cells, while DesiCorp specializes in advanced lyophilization techniques that ensure sensitive biological materials can be stored without refrigeration. By combining their competencies, they intend to roll out commercially available freeze-dried mRBCs that could be utilized beyond conventional hospital settings, such as in battlefields, ambulances, or during humanitarian crises.

The Importance of Freeze-Dried mRBCs

The development of freeze-dried mRBCs represents a potential paradigm shift in the way blood products are stored and administered. Currently, many blood products require stringent storage conditions, which are often not accessible in remote or disaster-stricken areas. The ability to store blood in a freeze-dried format provides numerous advantages:

• - Extended Shelf-Life: Frozen mRBCs can last longer than conventional blood products, which typically have strict expiration dates.
• - Efficient Logistics: Transporting freeze-dried mRBCs requires less complex logistical support, reducing costs and enhancing accessibility during emergencies.
• - Versatile Use: These products can be deployed in various settings, from military frontlines to remote healthcare facilities where refrigeration may not be available.

Quotes from Leadership

Doug McConnell, Chief Executive Officer and Co-Founder of Safi Biotherapeutics, expressed enthusiasm about the collaboration, stating, "Early evidence suggests that mRBCs are well suited for freeze-drying. Having a scalable supply of freeze-dried red blood cells would revolutionize transport, storage, and stockpiling capabilities. DesiCorp's expertise in freeze-drying offers the perfect synergy for us at this critical juncture."

On the other hand, Brett Janis, Ph.D., Chief Executive Officer and Co-Founder of DesiCorp, emphasized the collaborative mission, stating, "Safi Biotherapeutics leads the charge in allogeneic blood cell manufacturing. We are committed to addressing urgent blood supply shortages for both military and civilian needs worldwide. Maintaining the integrity of cellular structure during cryopreservation and lyophilization is crucial, particularly in settings lacking refrigeration."

Safi Biotherapeutics and Their Vision

Founded in 2020, Safi Biotherapeutics focuses on biomanufacturing stem-cell-derived mRBCs, which serve as a versatile product suitable for various transfusion needs. Their advanced production systems have already caught the attention of the U.S. Department of Defense, particularly for its On-Demand Blood program. Safi's innovative approach addresses chronic transfusion challenges faced by patients with conditions like sickle-cell disease, as well as urgent transfusion needs in critical care environments.

DesiCorp and Their Expertise

DesiCorp Inc. has dedicated itself to eliminating medical supply shortages through innovative packaging solutions that extend the shelf-life of sensitive products. This includes a holistic approach to logistics, ensuring that essential therapeutic products can be stored and transported with reduced costs and complexity.

Conclusion

The collaboration between Safi Biotherapeutics and DesiCorp marks an exciting development in the field of biotechnology, providing new solutions that have the potential to save numerous lives by ensuring that blood products are readily available wherever they are needed most. As they work towards developing and optimizing the freeze-drying process, the healthcare landscape may witness a significant shift in how blood supplies are managed and delivered during emergencies.